AI-designed mRNA H5Nx vaccine achieves complete protection in animal challenge trials

EN
eFeedLink Newsdesk
6 Nov 2026
AI-designed mRNA H5Nx vaccine achieves complete protection in animal challenge trials

A University of Cambridge and DIOSynVax candidate protected all challenged animals against antigenically distinct H5N1 clades, while stockpiled vaccines protected only about half.

Share:LinkedInX